PALUMBO, CARLOTTA
 Distribuzione geografica
Continente #
EU - Europa 2.778
NA - Nord America 2.631
AS - Asia 2.543
SA - Sud America 214
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 67
OC - Oceania 3
AN - Antartide 1
Totale 8.334
Nazione #
US - Stati Uniti d'America 2.516
SG - Singapore 1.174
RU - Federazione Russa 1.040
IE - Irlanda 757
HK - Hong Kong 404
CN - Cina 366
SE - Svezia 269
VN - Vietnam 218
DE - Germania 199
BR - Brasile 146
BD - Bangladesh 143
FR - Francia 143
IT - Italia 129
GB - Regno Unito 78
CA - Canada 64
IN - India 57
KR - Corea 41
FI - Finlandia 36
MX - Messico 29
BJ - Benin 26
PL - Polonia 26
AR - Argentina 25
UA - Ucraina 22
JP - Giappone 20
IQ - Iraq 18
ID - Indonesia 17
ZA - Sudafrica 17
TR - Turchia 16
NL - Olanda 15
PE - Perù 13
ES - Italia 12
EC - Ecuador 9
MY - Malesia 9
LT - Lituania 7
MA - Marocco 7
PH - Filippine 7
PK - Pakistan 7
RO - Romania 7
TH - Thailandia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
SA - Arabia Saudita 6
AT - Austria 5
BE - Belgio 5
CH - Svizzera 5
CO - Colombia 5
IL - Israele 5
JM - Giamaica 5
NP - Nepal 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
PR - Porto Rico 4
TN - Tunisia 4
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
LV - Lettonia 3
PY - Paraguay 3
RS - Serbia 3
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
KZ - Kazakistan 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SR - Suriname 1
ST - Sao Tome e Principe 1
UY - Uruguay 1
Totale 8.237
Città #
Dublin 755
Council Bluffs 422
Hong Kong 403
Singapore 370
San Jose 306
Ashburn 224
Beijing 167
Columbus 119
Lauterbourg 111
Lawrence 107
Princeton 107
Los Angeles 94
Santa Clara 88
Bremen 78
Moscow 72
Ho Chi Minh City 66
New York 53
Hanoi 48
Buffalo 41
Seoul 39
Helsinki 34
Boardman 32
Munich 29
Cotonou 26
São Paulo 24
Warsaw 22
Dallas 21
Orem 21
Toronto 21
Atlanta 20
Chennai 20
Montreal 20
Brooklyn 18
Phoenix 18
London 17
Mexico City 17
Rome 17
Tokyo 17
Chicago 16
Frankfurt am Main 16
Boston 14
Milan 14
Denver 11
Houston 11
Lima 11
Novara 11
Amsterdam 10
Ankara 10
Falkenstein 10
Genoa 10
Jacksonville 10
Johannesburg 10
Mumbai 10
San Francisco 10
Guangzhou 9
Manchester 9
Poplar 9
Stockholm 9
Baghdad 8
Paris 8
St Louis 8
Turin 8
Dhaka 7
Nuremberg 7
Tianjin 7
Assago 6
Biên Hòa 6
Haiphong 6
Kuala Lumpur 6
Portland 6
Seattle 6
Wilmington 6
Barnet 5
Bucharest 5
Can Tho 5
Charlotte 5
Guayaquil 5
Hải Dương 5
San Juan 5
Tashkent 5
Alessandria 4
Arezzo 4
Brno 4
Brussels 4
Chandler 4
City of London 4
Da Nang 4
Des Moines 4
Hangzhou 4
Lahore 4
Las Vegas 4
Ottawa 4
Padua 4
Pittsburgh 4
Roubaix 4
Bangkok 3
Belo Horizonte 3
Berlin 3
Bismarck 3
Brasília 3
Totale 4.494
Nome #
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 237
Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? 131
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols 122
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 111
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma 102
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 101
Is active surveillance a safe option for small RCCs as it is for small renal masses? 99
Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma 96
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 92
Bone mineral density and frax score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies 91
Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models 90
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 90
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 88
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 87
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern 86
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 84
Bladder cancer incidence rates and trends in young adults aged 20-39 years 82
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 82
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 82
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 81
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages 80
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 79
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 77
Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes 77
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: A systematic review 76
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 76
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 75
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 69
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group 69
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis 68
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update 67
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer 67
Sex- and age-related differences in the distribution of bladder cancer metastases 67
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. 66
Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis 66
Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report 66
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) 65
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 65
Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature 65
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 65
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 63
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 63
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay 62
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 62
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 62
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy 62
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 62
Robotic prostatectomy: An update on functional and oncologic outcomes 62
Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group 61
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 61
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 61
Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma 60
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263 60
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration 60
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 60
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 60
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy 59
Concordance between biopsy and radical prostatectomy specimen gleason score in internal and external pathology facilities 59
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder 59
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities 58
Perineural invasion as a predictor of extraprostatic extension of prostate cancer: A systematic review and meta-analysis 57
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 57
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 57
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm 56
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 56
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 56
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 56
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 56
Prostate cancer characteristics and cancer-specific mortality of Native American patients 55
Partial vs. radical nephrectomy in pT3a renal cancer: Cancer-specific mortality according to fat invasion pattern 54
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 54
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 54
Partial nephrectomy in frail patients: Benefits of robot-assisted surgery 54
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 53
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 53
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 53
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 53
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 53
Massive recurring angiomyxoma of the scrotum in a obese man 53
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 53
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 53
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 53
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 52
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 52
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 52
Reply to Wei Qi’s letter to the editor about “Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma” 51
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 51
Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience 51
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 50
Salvage treatment of local recurrence following radical and partial nephrectomy 50
Primary lymphomas of the genitourinary tract: A population-based study 49
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors 49
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer 48
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 48
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological Subtypes 47
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 47
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 47
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder 47
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 47
Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients 46
Totale 6.738
Categoria #
all - tutte 51.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 2 1 2 0 0 0 0 5 0 13 110
2022/20231.206 142 70 53 3 80 67 13 75 687 7 7 2
2023/2024458 17 34 40 15 100 0 145 2 3 6 8 88
2024/20251.444 42 3 67 9 26 43 163 86 442 300 21 242
2025/20264.182 203 231 185 349 352 273 613 671 276 483 200 346
2026/2027894 390 504 0 0 0 0 0 0 0 0 0 0
Totale 8.334